Pharmabiz15h
Shilpa Biologicals inks pact with mAbTree Biologics for a novel immuno-oncology asset
Shilpa Biologicals inks pact with mAbTree Biologics for a novel immuno-oncology asset: Our Bureau, Bengaluru Wednesday, March ...
Pharmabiz15h
HaystackAnalytics unveils ‘TB One’ solution to strengthen India's TB control efforts
HaystackAnalytics unveils ‘TB One’ solution to strengthen India's TB control efforts: Our Bureau, Bengaluru Wednesday, March ...
Pharmabiz10h
Garmin with Harvard and Oxford university researchers share initial findings from a Health and Happiness Study
Garmin with Harvard and Oxford university researchers share initial findings from a Health and Happiness Study: Our Bureau, Bengaluru Wednesday, March 19, 2025, 17:50 Hrs [IST] Ga ...
Pharmabiz10h
RedVersity by Red Health equips Cult.fit’s workforce with critical emergency response training
RedVersity by Red Health equips Cult.fit’s workforce with critical emergency response training: Our Bureau, Bengaluru Wednesday, March 19, 2025, 17:45 Hrs [IST] RedVersity, the ...
Pharmabiz10h
Tech Mahindra and NVIDIA to advance drug safety with agentic AI-powered pharmacovigilance solution
Tech Mahindra and NVIDIA to advance drug safety with agentic AI-powered pharmacovigilance solution: Our Bureau, Bengaluru Wednesday, March 19, 2025, 17:40 Hrs [IST] Tech Mahindra, ...
Pharmabiz14h
Cellogen Therapeutics gets DCGI nod to develop indigenous Bi-Specific 3rd Generation CAR T cells for cancer
Our Bureau, Bengaluru Wednesday, March 19, 2025, 13:15 Hrs [IST] ...
Pharmabiz12h
AFMS and NIMHANS sign MoU for collaborative research and training mental health and neurosciences
AFMS and NIMHANS sign MoU for collaborative research and training mental health and neurosciences: Our Bureau, Bengaluru Wednesday, March 19, 2025, 15:45 Hrs [IST] National Instit ...
Pharmabiz10h
Hoth Therapeutics announces positive preclinical results for HT-KIT in aggressive cancer gastrointestinal stromal tumours
Hoth Therapeutics announces positive preclinical results for HT-KIT in aggressive cancer gastrointestinal stromal tumours: New York Wednesday, March 19, 2025, 18:00 Hrs [IST] Hoth ...
Pharmabiz14h
US FDA grants Fast Track designation to Johnson & Johnson’s nipocalimab to treat adult patients with moderate-to-severe Sjögren’s disease
Spring House, Pennsylvania Wednesday, March 19, 2025, 14:00 Hrs [IST] ...
Pharmabiz12h
Virax Biolabs begins enrolling patients in clinical study assessing T cell dysfunction in post-acute infection syndromes
Virax Biolabs begins enrolling patients in clinical study assessing T cell dysfunction in post-acute infection syndromes: London Wednesday, March 19, 2025, 16:00 Hrs [IST] Virax B ...
Pharmabiz10h
Indegene expands presence in Europe; opens new centre in London
Indegene expands presence in Europe; opens new centre in London: Our Bureau, Bengaluru Wednesday, March 19, 2025, 17:30 Hrs [IST] Indegene, a digital-first life sciences commercia ...
Pharmabiz15h
Oncorena receives US FDA approval to initiate studies in US
Oncorena, a Swedish pharma company, announced that the US FDA has approved the company’s IND application to initiate the phase I/II study Oncorella-1: A phase 1/2, open label, single arm study on ...